Actively Recruiting
The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.
Led by Kutahya Health Sciences University · Updated on 2025-09-03
50
Participants Needed
1
Research Sites
80 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Back pain is commonly seen in the working-age population, with the peak occurrence around the age of 40. Its frequency does not increase with age and is not associated with age-related degenerative changes in the spine. Especially when the underlying cause is conditions such as myofascial pain syndrome (MPS), where regional muscle sensitivity in the rhomboid and trapezius areas is prominent, dry needling treatment has become increasingly popular and the subject of numerous studies in recent years. In the diagnosis of MPS, two valuable findings include the detection of a taut band upon palpation and the presence of trigger points in muscle fibers with mild finger pressure. The study we are planning involves a double-blind efficacy trial where real and sham dry needling procedures will be performed under ultrasound guidance, ensuring that both the patient and the evaluator are blinded. This study design has the potential to make a significant contribution to the literature in this field.
CONDITIONS
Official Title
The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinically diagnosed with dorsal myofascial pain syndrome with rhomboid and trapezius trigger points
- Shoulder pain with a Visual Analog Scale (VAS) score of 6 or higher
- Ability to read and write
You will not qualify if you...
- History of spinal surgery
- Skin lesions, atrophy, or scars around the back
- Received physiotherapy for back or lumbar region in the last 6 months
- Underwent an interventional procedure for back or lumbar pain in the last 3 months
- Used steroids in the last 1 month
- Presence of special conditions such as epilepsy, pregnancy, or injection phobia
- Unable to avoid steroid and non-steroidal anti-inflammatory drugs during the treatment period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kütahya Health Sciences University
Kütahya, Turkey (Türkiye), 43020
Actively Recruiting
Research Team
H
Hasan H Gökpınar, Ass. Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here